Last reviewed · How we verify
NCT05770245
Novel Electrolyzed Water Spray Treatment Mild Dermatophytosis
NA trial testing The novel electrolyzed water spray in Dermatophytoses in 14 participants. Completed in 1 February 2024.
20 July 2023
Quick facts
| Lead sponsor | Dove Medical Press Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 29 January 2023 |
| Primary completion | 20 July 2023 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- The novel electrolyzed water spray
Conditions studied
- Dermatophytoses — all drugs for Dermatophytoses →
Sponsor
Dove Medical Press Ltd — full company profile →
Who can join
Adults 20 to 70, any sex, with Dermatophytoses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test whether spraying the skin of patients of patients by use of the novel electrolyzed water spray will produce improvement in the condition of mild dermatophytosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Superficial Dermatophytosis across the World's Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges.
Keshwania P, Kaur N, Chauhan J, Sharma G, et al · · 2023 · cited 21× · PMID 37692246 · DOI 10.1021/acsomega.3c01988
Verify or expand the search:
- PubMed search for NCT05770245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of The novel electrolyzed water spray
Trials testing the same drug.
- NCT05792306 — The Novel Electrolyzed Water Spray Treatment Discomfort, Redness and Swelling of the Skin Surrounding the Wound · NA · completed
- NCT05766930 — The Novel Electrolyzed Water Spray Treatment the Genital Itching · NA · completed
- NCT05770258 — The Novel Electrolyzed Water Spray Treatment Mild Periodontitis · NA · completed
- NCT05770271 — The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis · NA · completed
Other Dove Medical Press Ltd trials
Trials by the same sponsor.
- NCT05809700 — Injection Therapy for Neuropathic Pain · NA · completed
- NCT05812300 — Local Injection of Periodontal Pocket Method for the Treatment of Gingivitis · NA · completed
- NCT05765513 — HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis · NA · completed
- NCT05770258 — The Novel Electrolyzed Water Spray Treatment Mild Periodontitis · NA · completed
- NCT05770271 — The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05770245 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dove Medical Press Ltd
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05770245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing